ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000229891.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.013877002	Resistant
ENSG00000229891.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.048986573	Sensitive